MARKET

BCTXW

BCTXW

BRIACELL THER
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8945
-0.0055
-0.61%
Closed 16:00 05/18 EDT
OPEN
0.8990
PREV CLOSE
0.9000
HIGH
0.8990
LOW
0.8850
VOLUME
726
TURNOVER
--
52 WEEK HIGH
1.990
52 WEEK LOW
0.6400
MARKET CAP
--
P/E (TTM)
-0.3687
1D
5D
1M
3M
1Y
5Y
BRIEF-Briacell Therapeutics Presents Clinical Data At The American Association For Cancer Research Annual Meeting 2021
reuters.com · 04/12 11:32
BriaCell Announces Closing of US$25 Million Public Offering
BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, BCTXW) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies...
GlobeNewswire · 02/26 19:24
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BCTXW. Analyze the recent business situations of BRIACELL THER through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
  • All
  • Financials
  • Insiders
No Data
About BCTXW
BriaCell Therapeutics Corp. is a Canada-based immuno-oncology focused biotechnology company developing targeted approaches for the management of cancer. The Company, in collaboration with Incyte Corporation, is conducting a Phase I/IIa clinical trial of Bria-IMT in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS is designed to produce a potent and selective immune response against the cancer of each patient while eliminating the time, expense and manufacturing logistics associated with other personalized immunotherapies.

Webull offers kinds of Briacell Therapeutics Corp stock information, including NASDAQ:BCTXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BCTXW stock methods without spending real money on the virtual paper trading platform.